Clinical Trial Update: HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

View source ↗

Summary

The Uganda trial is completed and reports immunogenicity data for HPV-16 and HPV-18 antibodies after partial vaccination with HPV vaccines in girls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Human Papillomavirus Infection
• Oropharyngeal Cancer

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)
• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HPV16 Anitbody Levels Post Vaccination, HPV18 Antibody Levels Post Vaccination | Status: COMPLETED